đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The primary objective of the present study is to investigate the influence ...
Status
Completed
Location
PRA Hungary Ltd., Phase I. Clinical Pharmacology Unit
Start Date
2013-02-04
Trial ID
NCT01772563
Treatments Being Tested
The primary objective of this trial is to identify the maximum tolerated do...
Status
Completed
Location
1230.1.32002 Boehringer Ingelheim Investigational Site
Start Date
2005-11-04
Trial ID
NCT02273388
Treatments Being Tested
To identify the maximum tolerated dose or recommended dose for further deve...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2014-08
Trial ID
NCT02201329
Treatments Being Tested
To investigate safety, tolerability, maximum tolerated dose of volasertib i...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2012-08
Trial ID
NCT01662505
Treatments Being Tested
The present trial will be performed according to an open design to determin...
Status
Completed
Location
UNIV UZ Gent
Start Date
2013-10-22
Trial ID
NCT01971476
Treatments Being Tested
To investigate the maximum tolerated dose (MTD), safety, pharmacokinetics, ...
Status
Terminated
Location
1230.33.33002 Boehringer Ingelheim Investigational Site
Start Date
2013-11-06
Trial ID
NCT01957644
Treatments Being Tested
To investigate the efficacy, safety, and pharmacokinetics of intravenous vo...
Status
Completed
Location
University of California
Start Date
2013-01-29
Trial ID
NCT01721876
Treatments Being Tested
The primary objective of the current study is to investigate the Maximum To...
Status
Completed
Location
1230.20.32001 Boehringer Ingelheim Investigational Site
Start Date
2010-10-04
Trial ID
NCT01206816
Treatments Being Tested
Investigation of absorption, distribution, metabolism and excretion (ADME) ...
Status
Completed
Location
1230.23.36001 Boehringer Ingelheim Investigational Site
Start Date
2010-06
Trial ID
NCT01145885
Treatments Being Tested
The objectives of this trial are to evaluate the safety, tolerability, maxi...
Status
Terminated
Location
University of Fukui Hospital
Start Date
2016-04-28
Trial ID
NCT02721875
Treatments Being Tested